Drug name - Supprelin La

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8062652 ENDO PHARM Compositions and methods for treating precocious puberty Jun, 2026

(3 years from now)

Drugs and Companies using HISTRELIN ACETATE ingredient

Treatment: Method of treatment of children with central precocious puberty

Dosage: IMPLANT;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
50MG IMPLANT;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.